USA Rapid Diagnostic Testing for Influenza Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Rapid Diagnostic Testing for Influenza companies are mainly from North America; the industry concentrate rate is relatively high. The top three companies are Thermo Fisher Scientific, BioMerieux and Princeton BioMeditech Corporation with the revenue market share of 24.71%, 24.08% and 13.12% in 2019.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Rapid Diagnostic Testing for Influenza market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Rapid Diagnostic Testing for Influenza market. Detailed analysis of key players, along with key growth strategies adopted by Rapid Diagnostic Testing for Influenza industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Thermo Fisher Scientific

    • BioMerieux

    • Princeton BioMeditech Corporation

    • Abbott

    • BD

    • SA Scientific

    • Quidel

    • Response Biomedical

    • Meridian Bioscience

    • Sekisui Diagnostics

    By Type:

    • Type A Flu

    • Type B Flu

    By End-User:

    • Point-of-care Testing Hospitals

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Rapid Diagnostic Testing for Influenza Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Type A Flu from 2016 to 2027

      • 1.3.2 USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Type B Flu from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Point-of-care Testing Hospitals from 2016 to 2027

      • 1.4.2 USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Rapid Diagnostic Testing for Influenza Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Rapid Diagnostic Testing for Influenza by Major Types

      • 3.4.1 Market Size and Growth Rate of Type A Flu

      • 3.4.2 Market Size and Growth Rate of Type B Flu

    4 Segmentation of Rapid Diagnostic Testing for Influenza Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Rapid Diagnostic Testing for Influenza by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Rapid Diagnostic Testing for Influenza in Point-of-care Testing Hospitals

      • 4.4.2 Market Size and Growth Rate of Rapid Diagnostic Testing for Influenza in Others

    5 Market Analysis by Regions

    • 5.1 USA Rapid Diagnostic Testing for Influenza Production Analysis by Regions

    • 5.2 USA Rapid Diagnostic Testing for Influenza Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Rapid Diagnostic Testing for Influenza Landscape Analysis

    • 6.1 West USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major Types

    • 6.2 West USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major End-Users

    7 South USA Rapid Diagnostic Testing for Influenza Landscape Analysis

    • 7.1 South USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major Types

    • 7.2 South USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major End-Users

    8 Middle West USA Rapid Diagnostic Testing for Influenza Landscape Analysis

    • 8.1 Middle West USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major Types

    • 8.2 Middle West USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major End-Users

    9 Northeast USA Rapid Diagnostic Testing for Influenza Landscape Analysis

    • 9.1 Northeast USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major Types

    • 9.2 Northeast USA Rapid Diagnostic Testing for Influenza Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Thermo Fisher Scientific

        • 10.1.1 Thermo Fisher Scientific Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 BioMerieux

        • 10.2.1 BioMerieux Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Princeton BioMeditech Corporation

        • 10.3.1 Princeton BioMeditech Corporation Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Abbott

        • 10.4.1 Abbott Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 BD

        • 10.5.1 BD Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 SA Scientific

        • 10.6.1 SA Scientific Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Quidel

        • 10.7.1 Quidel Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Response Biomedical

        • 10.8.1 Response Biomedical Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Meridian Bioscience

        • 10.9.1 Meridian Bioscience Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Sekisui Diagnostics

        • 10.10.1 Sekisui Diagnostics Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Type A Flu from 2016 to 2027

    • Figure USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Type B Flu from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Point-of-care Testing Hospitals from 2016 to 2027

    • Figure USA Rapid Diagnostic Testing for Influenza Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Rapid Diagnostic Testing for Influenza Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Rapid Diagnostic Testing for Influenza Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Rapid Diagnostic Testing for Influenza

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Rapid Diagnostic Testing for Influenza by Different Types from 2016 to 2027

    • Table Consumption Share of Rapid Diagnostic Testing for Influenza by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Type A Flu

    • Figure Market Size and Growth Rate of Type B Flu

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Rapid Diagnostic Testing for Influenza by Different End-Users from 2016 to 2027

    • Table Consumption Share of Rapid Diagnostic Testing for Influenza by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Point-of-care Testing Hospitals

    • Figure Market Size and Growth Rate of Others

    • Table USA Rapid Diagnostic Testing for Influenza Production by Regions

    • Table USA Rapid Diagnostic Testing for Influenza Production Share by Regions

    • Figure USA Rapid Diagnostic Testing for Influenza Production Share by Regions in 2016

    • Figure USA Rapid Diagnostic Testing for Influenza Production Share by Regions in 2021

    • Figure USA Rapid Diagnostic Testing for Influenza Production Share by Regions in 2027

    • Table USA Rapid Diagnostic Testing for Influenza Consumption by Regions

    • Table USA Rapid Diagnostic Testing for Influenza Consumption Share by Regions

    • Figure USA Rapid Diagnostic Testing for Influenza Consumption Share by Regions in 2016

    • Figure USA Rapid Diagnostic Testing for Influenza Consumption Share by Regions in 2021

    • Figure USA Rapid Diagnostic Testing for Influenza Consumption Share by Regions in 2027

    • Table West USA Rapid Diagnostic Testing for Influenza Consumption by Types from 2016 to 2027

    • Table West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types from 2016 to 2027

    • Figure West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2016

    • Figure West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2021

    • Figure West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2027

    • Table West USA Rapid Diagnostic Testing for Influenza Consumption by End-Users from 2016 to 2027

    • Table West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2016

    • Figure West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2021

    • Figure West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2027

    • Table South USA Rapid Diagnostic Testing for Influenza Consumption by Types from 2016 to 2027

    • Table South USA Rapid Diagnostic Testing for Influenza Consumption Share by Types from 2016 to 2027

    • Figure South USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2016

    • Figure South USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2021

    • Figure South USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2027

    • Table South USA Rapid Diagnostic Testing for Influenza Consumption by End-Users from 2016 to 2027

    • Table South USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2016

    • Figure South USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2021

    • Figure South USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2027

    • Table Middle West USA Rapid Diagnostic Testing for Influenza Consumption by Types from 2016 to 2027

    • Table Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2016

    • Figure Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2021

    • Figure Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2027

    • Table Middle West USA Rapid Diagnostic Testing for Influenza Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2016

    • Figure Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2021

    • Figure Middle West USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2027

    • Table Northeast USA Rapid Diagnostic Testing for Influenza Consumption by Types from 2016 to 2027

    • Table Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2016

    • Figure Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2021

    • Figure Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by Types in 2027

    • Table Northeast USA Rapid Diagnostic Testing for Influenza Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2016

    • Figure Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2021

    • Figure Northeast USA Rapid Diagnostic Testing for Influenza Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of BioMerieux

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux

    • Figure Sales and Growth Rate Analysis of BioMerieux

    • Figure Revenue and Market Share Analysis of BioMerieux

    • Table Product and Service Introduction of BioMerieux

    • Table Company Profile and Development Status of Princeton BioMeditech Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Princeton BioMeditech Corporation

    • Figure Sales and Growth Rate Analysis of Princeton BioMeditech Corporation

    • Figure Revenue and Market Share Analysis of Princeton BioMeditech Corporation

    • Table Product and Service Introduction of Princeton BioMeditech Corporation

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of BD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BD

    • Figure Sales and Growth Rate Analysis of BD

    • Figure Revenue and Market Share Analysis of BD

    • Table Product and Service Introduction of BD

    • Table Company Profile and Development Status of SA Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SA Scientific

    • Figure Sales and Growth Rate Analysis of SA Scientific

    • Figure Revenue and Market Share Analysis of SA Scientific

    • Table Product and Service Introduction of SA Scientific

    • Table Company Profile and Development Status of Quidel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quidel

    • Figure Sales and Growth Rate Analysis of Quidel

    • Figure Revenue and Market Share Analysis of Quidel

    • Table Product and Service Introduction of Quidel

    • Table Company Profile and Development Status of Response Biomedical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Response Biomedical

    • Figure Sales and Growth Rate Analysis of Response Biomedical

    • Figure Revenue and Market Share Analysis of Response Biomedical

    • Table Product and Service Introduction of Response Biomedical

    • Table Company Profile and Development Status of Meridian Bioscience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meridian Bioscience

    • Figure Sales and Growth Rate Analysis of Meridian Bioscience

    • Figure Revenue and Market Share Analysis of Meridian Bioscience

    • Table Product and Service Introduction of Meridian Bioscience

    • Table Company Profile and Development Status of Sekisui Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sekisui Diagnostics

    • Figure Sales and Growth Rate Analysis of Sekisui Diagnostics

    • Figure Revenue and Market Share Analysis of Sekisui Diagnostics

    • Table Product and Service Introduction of Sekisui Diagnostics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.